Home › Funds › Parkman Healthcare Partners LLC › CVS

Parkman Healthcare Partners LLC position in CVS

CVS HEALTH CORP · Consumer Staples

Parkman Healthcare Partners LLC reported holding 286,286 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$24.5M, representing 2.21% of its reported portfolio and ranking #10 among its reported holdings. Parkman Healthcare Partners LLC has disclosed CVS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)286.29K sh
Reported value held$24.53M
Portfolio Weight2.21%
First reportedQ4 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's CVS position evolved

Parkman Healthcare Partners LLC first disclosed a stake in CVS in Q4 2024 at 180,000 shares (US$8.1M). The position peaked in Q2 2026 at 391,791 shares, worth US$40.5M. Across 8 filings, Parkman Healthcare Partners LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 286,286 shares valued at US$24.5M — a reduction of -105,505 shares quarter over quarter.. Notable position changes include a 176% increase in Q1 2025 (shares rose 3% over the following quarter), a 27% trim in Q3 2025 (shares rose 6% over the following quarter), a 27% trim in Q3 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 180.00K $8.08M New
Q1 2025 496.74K $33.65M Add
Q2 2025 517.81K $35.72M Add
Q3 2025 379.49K $28.61M Reduce
Q4 2025 450.21K $35.73M Add
Q1 2026 387.31K $27.82M Reduce
Q2 2026 391.79K $40.53M Add
Q3 2026 286.29K $24.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 29 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held CVS?

Parkman Healthcare Partners LLC has disclosed CVS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Parkman Healthcare Partners LLC's current position in CVS?

As of Q3 2026, Parkman Healthcare Partners LLC holds 286.29K shares of CVS (CVS HEALTH CORP), valued at $24.53M, representing 2.21% of its reported portfolio and ranking #10.

Has Parkman Healthcare Partners LLC been buying or selling CVS?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in CVS. The position peaked in Q2 2026 at 391.79K shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.